Abbott plans to separate its global nutrition business into a public company. The plan could let Abbott focus on other businesses, but it would also separate a business Abbott owns, and the filing gives no timing or expected financial results.
The plan could let Abbott focus on its other businesses. But Abbott would also separate a business it owns, and the filing gives no timing or expected financial results. This filing alone does not show whether the plan helps or hurts Abbott.
Follow Abbott Laboratories (ABT) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for ABT